Aerie Pharmaceuticals, Inc. to Ring the NASDAQ Stock Market Closing Bell in Celebration of IPO

Published: Oct 25, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ADVISORY, Oct. 25, 2013 (GLOBE NEWSWIRE) -- What: Aerie Pharmaceuticals [AERI], a clinical-stage pharmaceutical company that focuses on the treatment of glaucoma, will visit the NASDAQ MarketSite in Times Square in celebration of its initial public offering (IPO) which occurred on the NASDAQ Stock Market today, October 25.

Help employers find you! Check out all the jobs and post your resume.

Back to news